EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

An inflatable balloon catheter and liquid 125I radiation source (GliaSite Radiation Therapy System) for treatment of recurrent malignant glioma: multicenter safety and feasibility trial



An inflatable balloon catheter and liquid 125I radiation source (GliaSite Radiation Therapy System) for treatment of recurrent malignant glioma: multicenter safety and feasibility trial



Journal of Neurosurgery 99(2): 297-303



Object. In this study the authors evaluated the safety and performance of the GliaSite Radiation Therapy System (RTS) in patients with recurrent malignant brain tumors who were undergoing tumor resection. Methods. The GliaSite is an inflatable balloon catheter that is placed in the resection cavity at the time of tumor debulking.

(PDF emailed within 0-6 h: $19.90)

Accession: 010162298

Download citation: RISBibTeXText

PMID: 12924704

DOI: 10.3171/jns.2003.99.2.0297



Related references

Brachytherapy of re-resected malignant glioma cavity margins using an inflatable balloon catheter and liquid 125I source A Phase I study. Journal of Nuclear Medicine 41(5 Suppl ): 274P, 2000

The GliaSite radiation therapy system A novel approach to brain brachytherapy for recurrent malignant glioma. International Journal of Radiation Oncology Biology Physics 51(3 Supplement 1): 203, 2001

Feasibility and safety of outpatient brachytherapy in 37 patients with brain tumors using the GliaSite Radiation Therapy System. Medical Physics 35(7): 3383-3388, 2008

Results of a phase II trial of the GliaSite radiation therapy system for the treatment of newly diagnosed, resected single brain metastases. Journal of Neurosurgery 105(3): 375-384, 2006

Radiation safety considerations in GliaSite 125I brain implant procedures. Health Physics 86(5 Suppl): S120-S123, 2004

A randomized trial of accelerated hyperfractionated radiation therapy and bis-chloroethyl nitrosourea for malignant glioma. A preliminary report of Radiation Therapy Oncology Group 83-02. Cancer 70(12): 2909-2917, 1992

Hyperfractionated radiation therapy and bischlorethylnitrosourea in the treatment of malignant glioma: Possible advantage observed at 72.0 Gy in 1.2 Gy B.I.D. fractions: Report of the Radiation Therapy Oncology Group Protocol 8302. International Journal of Radiation Oncology Biology Physics 25(2): 193-207, 1993

White matter changes are correlated significantly with radiation dose. Observations from a randomized dose-escalation trial for malignant glioma (Radiation Therapy Oncology Group 83-02). Cancer 74(10): 2828-2835, 1994

Experimental validation of dose calculation algorithms for the GliaSite RTS, a novel 125I liquid-filled balloon brachytherapy applicator. Medical Physics 28(1): 73-85, 2001

Radiation dose measurement of a balloon-catheter filled with liquid RE-188 by means of a LTD-system. Journal of Nuclear Medicine 39(5 SUPPL ): 84P, 1998

Safety and feasibility of the IVUS-Balloon Megasonics catheter A multicenter investigation. Journal of the American College of Cardiology 37(2 Supplement A): 79A, February, 2001

Multicenter study on the safety and feasibility of the intravenous ultrasound-balloon megasonics catheter. American Journal of Cardiology 86(Suppl 8A): 102i-103i, October 16, 2000

Feasibility and safety of robot-assisted salvage prostatectomy for recurrent prostate cancer following radiation therapy. Journal of Robotic Surgery 2(2): 81-83, 2008

The safety of interstitial chemotherapy with BCNU-loaded polymer followed by radiation therapy in the treatment of newly diagnosed malignant gliomas: phase I trial. Journal of Neuro-Oncology 26(2): 111-123, 1995